Zacks Investment Research downgraded shares of NOVADAQ TEC INC (NVDQ) from OUTPERFORM to NEUTRAL on March 15, 2013, with a target price of $11.20.
Novadaq Technologies Inc. develops, manufactures and markets real-time fluorescence imaging products for use in the operating room and other clinical settings. The company's key markets include plastic reconstructive, gastrointestinal, cardiac and general surgery. It provides SPY imaging systems which enables surgeons to the visualize blood flow in vessels, co-joined vessels and micro-vessels. Novadaq Technologies Inc. is headquartered in Mississauga, Canada.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on NOVADAQ TEC INC (NVDQ),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment